Europe Injectable Drug Delivery Market Trends & Size | 2031
Europe Injectable Drug Delivery Market Trends & Size | 2031
Segments - Europe Injectable Drug Delivery Market by Device Types (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices [Prefilled Syringes, Injectable Pens, Auto Injectors, Needle-free Injectors, and Others]), Therapeutic Applications (Cardiovascular Disease, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Others), and Geography (Germany, The UK, France, Italy, Spain, and Rest of Europe) - Europe Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 –2031
Upcoming
| Report ID :HC-3327
| 4.5 Rating
| 63 Reviews
| 165 Pages
| Format :
Report Description
Europe Injectable Drug Delivery Market Outlook
The Europe Injectable Drug Delivery Market size was valued at USD 262.45 Billion in 2022 and is expected to surpass USD 763.65 Billion by 2031, expanding at a CAGR of 12.6% during the forecast period, 2023–2031. The growth of the market is attributed to increasing use of biologics.
Injectable drug delivery system is infusion method, which allocates drug into body by piercing the syringe attached to the needle. Injectable drug delivery systems are well known and highly accepted due to their rapid action with the high effectiveness. Most preferred route includes intravenous (IV), subcutaneous (SC), and Intramuscular (IM).
The COVID-19 pandemic positively impacted the injectable drug delivery market due to various pharmaceutical companies have started revising their packaging and sterilization suppliers in order to update their offerings.
Europe Injectable Drug Delivery Market Trends, Drivers, Restraints, and Opportunities
-
Rising patients interest from vial and syringe to ready to use (pre-filled) delivery system is projected to boost the market growth in the coming years.
-
Increasing incidence of chronic diseases is anticipated to the market growth during the forecast period.
-
Growing management of product life cycle and advanced technologies is estimated to spur the market growth in the coming years.
-
Rising demand for vaccines, insulin, human growth hormone, and modern medicines is anticipated to drive the market growth during the forecast period.
-
Increasing consumer awareness across the region is projected to boost the market growth in the coming years.
-
Growing use of the systems and devices in administering drugs in unconscious and comatose patients and rise in partnerships, collaborations and acquisitions are estimated to spur the market growth in the coming years.
-
Rising health consciousness among consumers and investments to improve healthcare system are projected to boost the market growth in the coming years.
-
Growing geriatric population is anticipated to the market growth during the forecast period.
-
High number of needle stick injuries is estimated to restrict the market growth.
-
Contraceptive injectable preference for other mode of drug delivery can create challenges for the market.
-
Advancements in nanotechnology and others extend profitable has led to new opportunities in the market.
Scope of Europe Injectable Drug Delivery Market Report
The report on the Europe injectable drug delivery market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Europe Injectable Drug Delivery Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Device Types (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices [Prefilled Syringes, Injectable Pens, Auto Injectors, Needle-free Injectors, and Others]) and Therapeutic Applications (Cardiovascular Disease, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Others) |
|
Geography |
Germany, The UK, France, Italy, Spain, and Rest of Europe |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Baxter International; Becton; Dickinson and Company; Eli Lilly and Company; Gerresheimer AG; Novo Nordisk; Pfizer; Schott AG; Terumo Corporation; Teva Pharmaceutical Industries; and West Pharmaceutical Services Inc. |
Europe Injectable Drug Delivery Market Segment Insights
Conventional drug delivery devices segment to hold a significant market share
On the basis of device types, the market is divided into conventional drug delivery devices and self-injectable drug delivery devices. The self-injectable drug delivery devices segment is segregated into prefilled syringes, injectable pens, auto injectors, needle-free injectors, and others.
The self-injectable drug delivery devices segment is anticipated to hold a key share of the market in the coming years due to advantages of self-injectable injections and increasing awareness of self-administration.
However, the conventional drug delivery devices segment is anticipated to expand at a rapid pace during the forecast period due to reducing volume of distribution of drugs.
Oncology segment is projected to expand at a considerable CAGR
Based on therapeutic applications, the market is segregated into cardiovascular disease, diabetes, oncology, autoimmune disorders, hepatitis, and others. The cardiovascular disease segment is expected to represent a key share of the market in the upcoming years.
On the other hand, the oncology segment is anticipated to expand at a rapid pace during the forecast period owning to requirement for better cancer detection solutions.
Europe Injectable Drug Delivery Market Regional Outlook
The UK is estimated to account a major market share
On the basis of regions, the Europe injectable drug delivery market is classified as Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany is expected to constitute a key share of the market during the projected period due to growing healthcare expenditure and technological advances. However, the market in the UK is anticipated expand at a rapid pace during the forecast period.
Segments
Device Types
- Conventional Drug Delivery Devices
- Self-injectable Drug Delivery Devices
- Prefilled Syringes
- Injectable Pens
- Auto Injectors
- Needle-free Injectors
- Others
Therapeutic Applications
- Cardiovascular Disease
- Diabetes
- Oncology
- Autoimmune Disorders
- Hepatitis
- Others
Geography
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Key Players
- Baxter International
- Becton
- Dickinson and Company
- Eli Lilly and Company
- Gerresheimer AG
- Novo Nordisk
- Pfizer
- Schott AG
- Terumo Corporation
- Teva Pharmaceutical Industries
- West Pharmaceutical Services Inc.
Competitive Landscape
Key players competing in the Europe injectables drug delivery market includes Baxter International; Becton; Dickinson and Company; Eli Lilly and Company; Gerresheimer AG; Novo Nordisk; Pfizer; Schott AG; Terumo Corporation; Teva Pharmaceutical Industries; and West Pharmaceutical Services Inc.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Injectable Drug Delivery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Injectable Drug Delivery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Injectable Drug Delivery Market - Supply Chain
4.5. Global Injectable Drug Delivery Market Forecast
4.5.1. Injectable Drug Delivery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Injectable Drug Delivery Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Injectable Drug Delivery Market Absolute $ Opportunity
5. Global Injectable Drug Delivery Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Injectable Drug Delivery Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Injectable Drug Delivery Demand Share Forecast, 2019-2026
6. North America Injectable Drug Delivery Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Injectable Drug Delivery Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Injectable Drug Delivery Demand Share Forecast, 2019-2026
7. Latin America Injectable Drug Delivery Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Injectable Drug Delivery Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Injectable Drug Delivery Demand Share Forecast, 2019-2026
8. Europe Injectable Drug Delivery Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Injectable Drug Delivery Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Injectable Drug Delivery Demand Share Forecast, 2019-2026
9. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Injectable Drug Delivery Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Injectable Drug Delivery Demand Share Forecast, 2019-2026
10. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Injectable Drug Delivery Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Injectable Drug Delivery Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Injectable Drug Delivery Market: Market Share Analysis
11.2. Injectable Drug Delivery Distributors and Customers
11.3. Injectable Drug Delivery Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Baxter International
11.4.2. Becton
11.4.3. Dickinson and Company
11.4.4. Eli Lilly and Company
11.4.5. Gerresheimer AG
11.4.6. Novo Nordisk
11.4.7. Pfizer
11.4.8. Schott AG
Methodology
Related Reports
Some other reports from this category!
Our Clients
